Cancer Research AACR Membership  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 6031-6038, November 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Webster, M. K.
Right arrow Articles by Firestone, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Webster, M. K.
Right arrow Articles by Firestone, G. L.

Glucocorticoid Growth Suppression Response in 13762NF Adenocarcinoma-derived Con8 Rat Mammary Tumor Cells Is Mediated by Dominant Trans-acting Factors1

Melanie K. Webster, Janice Guthrie2 and Gary L. Firestone3

Department of Molecular and Cell Biology and the Cancer Research Laboratory, University of California at Berkeley, Berkeley, California 94720

The in vitro and in vivo growth of Con8 cells, a single cell-derived subclone of the 13762NF-transplantable rat mammary adenocarcinoma, is strongly suppressed by glucocorticoid hormones. Hybrids were formed between glucocorticoid-suppressible Con8.hD6 mammary tumor cells (Con8 transfected with the histidinol dehydrogenase selectable marker) and either glucocorticoid-resistant 8RUV7 mammary tumor cells (derived from Con8) or MCT-HTC rat hepatoma cells. Both of the glucocorticoid-resistant 8RUV7 and MCT-HTC fusion partners express functional glucocorticoid receptors, since hormone-responsive genes such as plasminogen activator inhibitor are fully dexamethasone inducible. Karyotypic analyses revealed that the hybrid cell populations possessed the appropriate number of chromosomes for a fusion between the glucocorticoid-suppressible and either of the two resistant cell types. Moreover, Northern blots showed that the intertissue hybrids expressed transcripts for both the milk fat globule membrane protein gene originating from the parental Con8.hD6 mammary tumor cells as well as mouse mammary tumor virus glycoprotein sequences which had been transfected into the MCT-HTC hepatoma cells as a molecular tag. Analysis of DNA content and [3H]thymidine incorporation demonstrated that growth of both the intratissue (Con8.hD6 x 8RUV7) and intertissue (Con8.hD6 x MCT-HTC) hybrids was glucocorticoid suppressible, even though the absolute rates of proliferation differed depending on the parental cells. Analysis of conditioned medium isolated from glucocorticoid-treated and untreated Con8.hD6 cells indicated that the growth suppression response is not mediated through the elaboration of an extracellular growth inhibitor. Taken together, our results demonstrate that the glucocorticoid-suppressible phenotype of Con8 rat mammary tumor cells is dominant, suggesting the existence of intracellular regulatory factors under glucocorticoid control that may function as trans-acting suppressors of tumor cell growth.

1 This work was supported by USPHS Grant CA-05388 awarded by the National Cancer Institute.

2 Postdoctoral trainee supported by National Research Service Grant CA-09041 awarded by the NIH.

3 To whom requests for reprints should be addressed, at Dept. of Molecular and Cell Biology, Box 591 LSA, University of California at Berkeley, Berkeley, CA 94720.

Received 6/10/91. Accepted 9/11/91.




This article has been cited by other articles:


Home page
EndocrinologyHome page
J. J. Tomlinson, A. Boudreau, D. Wu, E. Atlas, and R. J. G. Hache
Modulation of Early Human Preadipocyte Differentiation by Glucocorticoids
Endocrinology, November 1, 2006; 147(11): 5284 - 5293.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Guan, N. M. Rubenstein, K. L. Failor, P. L. Woo, and G. L. Firestone
Glucocorticoids Control {beta}-Catenin Protein Expression and Localization through Distinct Pathways that Can Be Uncoupled by Disruption of Signaling Events Required for Tight Junction Formation in Rat Mammary Epithelial Tumor Cells
Mol. Endocrinol., January 1, 2004; 18(1): 214 - 227.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Buse, S. H. Tran, E. Luther, P. T. Phu, G. W. Aponte, and G. L. Firestone
Cell Cycle and Hormonal Control of Nuclear-Cytoplasmic Localization of the Serum- and Glucocorticoid-inducible Protein Kinase, Sgk, in Mammary Tumor Cells. A NOVEL CONVERGENCE POINT OF ANTI-PROLIFERATIVE AND PROLIFERATIVE CELL SIGNALING PATHWAYS
J. Biol. Chem., March 12, 1999; 274(11): 7253 - 7263.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. Fan, J.-X. Ma, L. Cheng, and J. S. Norris
Molecular Cloning of TA16, a Transcriptional Repressor That May Mediate Glucocorticoid-Induced Growth Arrest of Leiomyosarcoma Cells
Mol. Endocrinol., August 1, 1997; 11(9): 1342 - 1352.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. Buse, P. L. Woo, D. B. Alexander, A. Reza, and G. L. Firestone
Glucocorticoid-induced Functional Polarity of Growth Factor Responsiveness Regulates Tight Junction Dynamics in Transformed Mammary Epithelial Tumor Cells
J. Biol. Chem., November 24, 1995; 270(47): 28223 - 28227.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Buse, P. L. Woo, D. B. Alexander, H. H. Cha, A. Reza, N. D. Sirota, and G. L. Firestone
Transforming Growth Factor-alpha Abrogates Glucocorticoid-stimulated Tight Junction Formation and Growth Suppression in Rat Mammary Epithelial Tumor Cells
J. Biol. Chem., March 24, 1995; 270(12): 6505 - 6514.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.